Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment
NCT01724723
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis
Tuberculosis
hepatitisB
Interventions
DRUG:
entecavir (BARACLUDE®)
Sponsor
National Taiwan University Hospital